Brimonidine Tartrate And Timolol Maleate Solution/ Drops
Product Images NDC 72603-931

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate And Timolol Maleate (NDC 72603-931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimo-timo-10ml-carton (Brimo Timo 10ml Carton)

Brimo-timo-10ml-carton (Brimo Timo 10ml Carton)
This is a product description for an ophthalmic solution with Brimonidine Tartrate and Timolol Maleate, indicated for treatment of a specific eye condition. The solution comes in a 10mL bottle and is used with a customary dosage of one drop twice daily. It includes the preservative benzalkonium chloride (0.005%) and other inactive ingredients to adjust pH levels. The product should be stored at room temperature and protected from light. The solution is sterile and is manufactured in India for Northstar Rx LLC.*
FDA Label Image

Brimo-timo-10ml-container (Brimo Timo 10ml Container)

Brimo-timo-10ml-container (Brimo Timo 10ml Container)
This is a prescription ophthalmic solution containing 0.2% Brimonidine Tartrate and 0.5% Timolol Maleate. It is used to treat eye conditions and comes in a 10 mL bottle. The solution should be stored at room temperature and protected from light. The recommended dosage is one drop twice daily in the affected eye(s). The solution is manufactured for Northstar Rx LLC and has an expiration date of 03/2026. It contains benzalkonium chloride as a preservative.*
FDA Label Image

Brimo-timo-5ml-carton (Brimo Timo 5ml Carton)

Brimo-timo-5ml-carton (Brimo Timo 5ml Carton)
This is a description for a sterile ophthalmic solution containing brimonidine tartrate 0.2% and timolol maleate 0.5%. The product is manufactured by Northstar Rx LLC and is used for ophthalmic purposes. It is advised to store the solution at a temperature between 20°C to 25°C and protect it from light. The solution is intended for use in the affected eye(s) twice daily.*
FDA Label Image

Brimo-timo-5ml-container (Brimo Timo 5ml Container)

Brimo-timo-5ml-container (Brimo Timo 5ml Container)
Description: This text provides information about an ophthalmic solution containing brimonidine tartrate 0.2% and timolol 0.5%. The usual dosage is one drop twice daily in the affected eye(s). The solution should be stored at 20°C to 25°C (66°F to 77°F) and protected from light. The product is manufactured for Northstar Rx LLC in Memphis, TN, and has a code number GO/DRUGS/557. Made in India.*
FDA Label Image

Brimonidine-tartrate-stru-jpg (Brimonidine Tartrate Str)

FDA Label Image

Timolol-maleate-stru-jpg (Timolol Maleate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.